Canadian Tissue Repository Network

Canadian Tissue Repository Network
Name	Canadian Tissue Repository Network
Abbreviation	CTRN
Formation	2000s
Type	Biobank network
Headquarters	Canada
Region served	Canada

Canadian Tissue Repository Network is a Canadian consortium coordinating human tissue biobanking across provincial health systems, academic hospitals, and research institutes. It supports translational research by linking pathology archives, clinical databases, and academic laboratories to facilitate studies in oncology, immunology, and genomics. The Network connects stakeholders from institutions such as University of Toronto, McGill University, University of British Columbia, Ontario Institute for Cancer Research, and BC Cancer Agency to enable shared access to curated biospecimens.

Overview

The Network aggregates formal biorepositories, pathology departments, and academic cores at sites including Toronto General Hospital, Montreal General Hospital, Vancouver General Hospital, Sunnybrook Health Sciences Centre, and Ottawa Civic Hospital to provide annotated tissue, blood, and nucleic acid resources. It enables researchers affiliated with organizations like Canadian Institutes of Health Research, Genome Canada, CIHR, Michael Smith Foundation for Health Research, and Cancer Research UK to pursue projects in molecular pathology, biomarker validation, and clinical trials. The consortium interfaces with technology platforms developed at Broad Institute, BC Cancer Genome Sciences Centre, McMaster University, University Health Network, and Lady Davis Institute to harmonize sample processing, metadata standards, and data sharing workflows.

History and Development

The initiative emerged from collaborations among academic pathology programs, provincial cancer agencies, and national funding bodies such as Canadian Cancer Society and CIHR following models like UK Biobank, National Cancer Institute (United States), and European Genome-phenome Archive. Early pilot projects involved tissue collections from consortia including Canadian Prostate Cancer Biomarker Network, Pan-Canadian Cancer Research Network, and hospital biobanks at Mount Sinai Hospital (Toronto), Jewish General Hospital, and McGill University Health Centre. Subsequent development integrated informatics approaches influenced by projects at The Cancer Genome Atlas, International Cancer Genome Consortium, dbGaP, and initiatives at Imperial College London and Karolinska Institutet.

Structure and Membership

Membership spans academic hospitals, provincial pathology labs, and research institutes such as BC Children’s Hospital Research Institute, Princess Margaret Cancer Centre, Élisabeth-Bruyère Hospital, St. Michael's Hospital, and The Ottawa Hospital Research Institute. Governing bodies include steering committees drawn from institutions like University of Alberta, Dalhousie University, Université de Montréal, Queen's University, and Simon Fraser University. Operational cores mirror models at Fred Hutchinson Cancer Research Center, Dana–Farber Cancer Institute, Sanger Institute, and Wellcome Trust, with centralized biorepository standards informed by International Society for Biological and Environmental Repositories and clinical data harmonization influenced by Health Level Seven International and Observational Health Data Sciences and Informatics collaborators.

Services and Activities

The Network provides services including standardized tissue collection, histopathology review, tissue microarray construction, DNA/RNA extraction, and digital slide scanning used by investigators at Children's Hospital of Eastern Ontario, Alberta Health Services, Island Health, SickKids Research Institute, and Mount Sinai Hospital (New York). It supports protocol development for clinical trials sponsored by groups such as Canadian Cancer Trials Group, European Organisation for Research and Treatment of Cancer, and National Surgical Adjuvant Breast and Bowel Project. Bioinformatics and data curation services align with resources from ArrayExpress, Gene Expression Omnibus, Ensembl, ClinVar, and dbSNP to enable integrative analyses by researchers at McGill Genome Centre and Toronto General Research Institute.

Governance and Funding

Governance incorporates institutional review boards and ethics boards from members like BC Cancer Research Ethics Board, Université Laval Ethics Committee, and Ottawa Health Science Network Research Ethics Board, with advisory input from funding agencies including CIHR, Genome Canada, Natural Sciences and Engineering Research Council of Canada, Health Canada, and philanthropic organizations such as Terry Fox Foundation and Movember Foundation. Financial models combine grant support, cost-recovery service fees, and partnerships with industry stakeholders like pharmaceutical companies, contract research organizations, and diagnostic developers collaborating with Sanofi, Roche, Pfizer, and AbbVie in Canada.

Privacy, Ethics, and Regulatory Compliance

The Network adheres to privacy frameworks and legislation such as Personal Information Protection and Electronic Documents Act, provincial health information statutes in Ontario, Quebec, and British Columbia, and regulatory guidance from Health Canada and international norms from Declaration of Helsinki, CIOMS, and Council for International Organizations of Medical Sciences. Ethics processes include research ethics board approvals, informed consent models used by institutions like The Ottawa Hospital, and data governance practices paralleling those at All of Us Research Program and UK Biobank to manage de-identification, access committees, and secondary-use policies.

Impact and Collaborations

The consortium has enabled studies leading to biomarker discovery and translational outputs in partnership with academic groups at University of Calgary, University of Manitoba, McMaster University, Université de Sherbrooke, and international collaborators at Johns Hopkins University, Harvard Medical School, Massachusetts General Hospital, Karolinska Institutet, and University College London. Outcomes include peer-reviewed publications, contributions to clinical guideline development by organizations like Canadian Task Force on Preventive Health Care and translational partnerships with diagnostics companies and cooperative groups such as Canadian Cancer Society Research Institute and Pan-Canadian Oncology Drug Review. The Network continues to expand specimen access, metadata linkage, and cross-institutional initiatives with provincial cancer agencies and international biobanking consortia.

Category:Biobanks in Canada